[1] Unsupervised microdosing without appropriate medical oversight could lead to inadequate treatment
Branded medications undergo FDA manufacturing oversight and stability testing under defined conditions
Efficacy of modern diabetes treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian patients with diabetes: a systematic review and meta-analysis of randomized controlled trials
Foods high in protein, fiber, and healthy fats can naturally support GLP-1 but putting that into practice consistently is where most people struggle
Table 2 summarizes the cardiovascular risk-relevant outcomes of large clinical trials such as the Diabetes therapy Utilization: Researching changes in A1c, weight and other factors Through Intervention with exenatide Once weekly (DURATION) trials of exenatide once-weekly, the Liraglutide Effect and Action in Diabetes (LEAD) studies of liraglutide, the Assessment of Weekly Administration of LY2189265 in Diabetes-1 (AWARD) studies of dulaglutide, the HARMONY studies of albiglutide, and the GetGoal studies of lixisenatide
For patients already taking GLP-1 medications, there is no need for alarm